Green JE - Search Results

1

Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin.

Gonzalez-Moreno O, Calvo A, Joshi BH, Abasolo I, Leland P, Wang Z, Montuenga L, Puri RK, Green JE. Gonzalez-Moreno O, et al. Among authors: green je. Int J Cancer. 2005 May 10;114(6):870-8. doi: 10.1002/ijc.20789. Int J Cancer. 2005. PMID: 15609296

2

Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.

Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE. Calvo A, et al. Among authors: green je. Cancer Res. 2002 Sep 15;62(18):5325-35. Cancer Res. 2002. PMID: 12235003

3

Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.

Joshi BH, Leland P, Calvo A, Green JE, Puri RK. Joshi BH, et al. Among authors: green je. Cancer Res. 2008 Nov 15;68(22):9311-7. doi: 10.1158/0008-5472.CAN-08-2810. Cancer Res. 2008. PMID: 19010904 Free PMC article.

4

Genomic approaches to understanding mammary tumor progression in transgenic mice and responses to therapy.

Green JE, Desai K, Ye Y, Kavanaugh C, Calvo A, Huh JI. Green JE, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):385S-90S. doi: 10.1158/1078-0432.ccr-031201. Clin Cancer Res. 2004. PMID: 14734496

5

Application of gene expression profiling for validating models of human breast cancer.

Green JE, Desai KV, Ye Y, Kavanaugh C, Calvo A, Huh JI. Green JE, et al. Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:84-9. doi: 10.1080/01926230490424897. Toxicol Pathol. 2004. PMID: 15209407 Review.

6

Prostate cancer and the genomic revolution: Advances using microarray analyses.

Calvo A, Gonzalez-Moreno O, Yoon CY, Huh JI, Desai K, Nguyen QT, Green JE. Calvo A, et al. Among authors: green je. Mutat Res. 2005 Aug 25;576(1-2):66-79. doi: 10.1016/j.mrfmmm.2004.08.019. Mutat Res. 2005. PMID: 15950992 Review.

7

Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.

Huh JI, Calvo A, Charles R, Green JE. Huh JI, et al. Among authors: green je. Cancer Res. 2006 Apr 1;66(7):3495-503. doi: 10.1158/0008-5472.CAN-04-2372. Cancer Res. 2006. PMID: 16585173

8

Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis.

Catena R, Muniz-Medina V, Moralejo B, Javierre B, Best CJ, Emmert-Buck MR, Green JE, Baker CC, Calvo A. Catena R, et al. Among authors: green je. Int J Cancer. 2007 May 15;120(10):2096-109. doi: 10.1002/ijc.22461. Int J Cancer. 2007. PMID: 17278099

9

Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.

Calvo A, Feldman AL, Libutti SK, Green JE. Calvo A, et al. Among authors: green je. Cancer Res. 2002 Jul 15;62(14):3934-8. Cancer Res. 2002. PMID: 12124322

10

Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.

Calvo A, Yokoyama Y, Smith LE, Ali I, Shih SC, Feldman AL, Libutti SK, Sundaram R, Green JE. Calvo A, et al. Among authors: green je. Int J Cancer. 2002 Sep 20;101(3):224-34. doi: 10.1002/ijc.10589. Int J Cancer. 2002. PMID: 12209972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters